Statement regarding Cambodian NHP supply

The November 16, 2022, indictment filed against the Cambodian breeder and Cambodian officials does not name or reference Labcorp.  The Early Development business has multiple global suppliers and requires its vendors to meet high regulatory compliance standards.  Ex-US sites do not use Cambodian NHP supply. The business is working to procure additional supply from other sources for our US operations. US NHP studies comprise less than 2% of overall enterprise Labcorp revenue.  

Physical activity helps employees to manage and even reduce risk of diabetes

As you’ve probably heard, many chronic diseases can be managed or outright prevented with physical activity. When it comes to diabetes, enabling employees to become more active through regular activity delivers a host of benefits.

Assessing variability across HRD assays: Findings from the friends’ HRD harmonization project

Comprehensive genomic and immune profiling of non-small cell lung cancer brain metastases reveals low tumor inflammation and elevated cancer testis antigen burden

Integration of multiple immune-associated biomarkers facilitates classification of solid tumors by primary immune escape mode and prediction of patient outcomes

The immune expression landscape of solid tumors with tertiary lymphoid structures

Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency

KIT(D816V) Digital PCR Testing